China-based Baird Medical Investment Holdings, a market leader in minimally invasive Microwave Ablation (MWA) technology, has announced a strategic partnership with Stonewood Key Capital, a wholly-owned comprehensive investment management enterprise from New Zealand.
This collaboration positions the Hainan Free Trade Port as a pivotal hub for the company's cross-border operations and supply chain, enabling more efficient capital allocation to accelerate the commercialisation of its advanced medical solutions globally.
Formalised at an official signing ceremony, this agreement reinforces Baird Medical's market leadership and serves as a cornerstone of its growth strategy. By capitalising on the Free Trade Port's advantageous policies regarding cross-border capital flows and personnel mobility, the company secures a competitive operational framework designed to meet rising demand for minimally invasive therapies addressing thyroid and other soft tissue applications.
The partnership utilises the region's integrated "Capital – Base-Service" ecosystem, empowering Baird Medical to deepen its footprint in the broader healthcare sector.
